. Beta-actin was blotted as a loading control for the immuno-blot. Note the equivalent expression of RNAi resistant DDX5 wild-type or mutant proteins after knockdown of endogenous DDX5 for the WCEs obtained from HCT116 cells expressing the transgenes compared to HCT116 cells infected with empty vector lacking an RNAi resistant Ddx5 transgene. The asterisk marks the upper band on the HA immuno-blot which is a non-specific cross-hybridizing band detected by this antibody. (B) Proliferation assay results for HCT116 cells expressing the different RNAi resistant Ddx5 transgenes with or without endogenous Ddx5 knockdown. In this assay, following infection of HCT116 cells with virus encoding either of the different shRNAs the HCT116 cells were seeded at low density in tissue culture plates and growth media to maintain selection for transgene and shRNA expression. After allowing 8 days for the cultures to expand they were stained with crystal violet as previously reported (Mazurek et al., 2012) . The cultures were then destained and the released stain was quantified using a spectrophotometer. The amount stain released from each culture expressing the indicated RNAi resistant Ddx5 transgene with DDX5 knockdown was then normalized to the stain released from the culture expressing the same RNAi resistant Ddx5 transgene but without DDX5 knockdown (shRen.713 control cultures 
RN2
Overlap Genes: Casp4, Cbr4, Ccng2, Chac1, Cth, Lyrm5, Pcyoc1l, Sepp1, and Stc2 HCT116 RN2 1160 220 15
Overlap Genes: Cbr4, Cth, Cyfip2, E2f2, Etv4, Glb1, Ifit2, Lpcat2, Mif, Pcyox1l, Sepp1, Sepw1, Stc2, Tst, and Usp11 (Zuber et al., 2011a) or genes that are downregulated after BRD4 knockdown (bottom) Zuber et al., 2011b) . 
DDX5 dependent genes
Overlap Genes: 1500012f01rik, cd320, mrpl12, pop1, slc7a5, slc16a1, and trub1 Overlap Genes: 1500012f01rik, slc7a5, slc16a1, slc19a1, ass1, cables1, chst13, cth, far2, fkbp4, gas5, gpt2, ifrd2, kcnn4, mgl2, nop56, oscp1, pecr, prssl1, and spns3 A five-fold cross-validation was applied through voting of neighboring genes was applied to estimate functional network connectivity. Essentially we attempted to determine with the cancer co-expression network we constructed from meta-analysis whether knowing four-fifths of genes annotated to a particular GO process or in the genes affected by DDX5 knockdown (q<0.05) would enable accurate prediction of the remaining one-fifth of genes in these gene sets. A receiver operator characteristic curve (ROC) score of 1.0 (x-axis) indicates that providing the cancer co-expression network enabled perfect prediction of the remaining one-fifth of genes and an ROC score of 0.5 indicates that our predictions were no better than random. The dark green vertical line on the plot shows the "learnability" from our cancer co-expression network of the differentially expressed genes by shDDX5.2086 vs.
shRen.713 at 24hrs after DDX5 knockdown, the light green line on the plot shows the learnability for shDDX5.1322 vs. shRen.713 differentially expressed genes at 24hrs after DDX5 knockdown, the dark red line shows the learnability for shDDX5.2086 vs. shRen.713 differentially expressed genes at 48hrs after DDX5 knockdown, and the light red line shows the learnability for shDDX5.1322 vs. shRen.713 differentially expressed genes at 48hrs. The black curve shows the results for the learnability of gene ontology processes by the cancer co-expression network. Highly significant results were obtained using our cancer co-expression network particularly when differentially expressed genes observed 48hrs after DDX5 knockdown were tested(ROC ~0.7 for both shDDX5.1322 and shDDX5.2086) indicating that DDX5 knockdown is altering the expression of genes significantly learnable by the cancer co-expression network (FDR ~ 1 x 10 -15 ).
(B) Results after subtracting ROC scores from the cancer and brain co-expression gene network analysis observed for gene ontology processes and genes affected by DDX5 knockdown by either of the two DDX5 shRNAs vs. control at either 24hrs or 48hrs after knockdown. Color-coding of the DDX5 RNAi vs. control differentially expressed gene sets at 24hrs and 48hrs after DDX5 knockdown as well as the gene ontology processes are the same as in (A). Note a value of 0 on the x-axis indicates that dropout genes for the GO process were predicted equally well from the cancer co-expression gene network as by the brain co-expression gene network. A positive value on the x-axis means that the dropout genes from the GO process or DDX5-dependent gene set were predicted better by the cancer co-expression gene network than by the brain co-expression gene network. Importantly, when the ROC scores obtained from the cancer and brain-based co-expression networks were subtracted this revealed that the differentially expressed genes resulting from DDX5 knockdown at both 24hrs and 48hrs after knockdown were very specifically learnable from the cancer co-expression networks compared to the brain-based co-expression networks ( Figure 4C , ROC difference >0.05) indicating that DDX5 is regulating the expression of genes much more specific for cancer than our control brain-based gene networks. Note that gene ontology processes are mostly equally learnable by the cancer co-expression network as by the brain-based co-expression network (most processes have ROC difference < 0.05). Thus the differentially expressed genes resulting from DDX5 knockdown in AML cells preferentially cluster in this analysis with the cancer gene networks than non-cancer gene networks. Genes in the tail-end distribution of the ROC differences (ROC difference > 0.05) are enriched for those that mediate "monosaccharide metabolic process" and "hexose metabolic process".
shDDX5: 1 2 p53 p53 S15-P 
SUPPLEMENTAL EXPERIMENTAL PROCEDURES Cell lines, plasmids, antibodies, and shRNAs:
All human and mouse AML cell lines as well as immortalized MEF cells were obtained as described (Zuber et al., 2011b) . The pLMN and pTRIN (pTRMPV-Neo) plasmids used to prepare retrovirus for transduction of either constitutive or doxycycline-inducible shRNA expression into human and mouse cell lines were generated as described (Zuber et al., 2011b) . pMSCVneomycin R -BCL2 was provided by Dr. Christopher Vakoc and the BCL2 transgene was cloned into the pMSCVpuromycin R plasmid (Clontech) for experiments. The plasmid encoding HA-DDX5 was generously provided by Ralf Janknecht (Shin et al., 2007) and the pLPC plasmid was generously provided by Scott
Lowe. HA-DDX5 was subcloned into the pLPC plasmid using PCR. Overlapping PCR was applied to introduce base substitutions into the HA-DDX5 transgene for the K144N Cell Proliferation Assay (For Figure S5B ):
In Figure S5B , cell proliferation was measured using crystal violet staining as previously described (Mazurek et al., 2012 plates. After allowing 8 days for the cultures to expand the cells were stained with crystal violet. Each wells was then destained with 10% glacial acetic acid and the absorbance of the released stain was quantitated at OD600 on an Eppendorf BioPhotometer.
In vivo mouse experiments:
All mouse experiments were approved by the Cold Spring Harbor Laboratory animal care and use committee. For the in vivo AML experiments these were performed as described (Zuber et al., 2011b) . The shRNAs targeting the DDX5 transcript were cloned into the 3' untranslated region of a dsRed transgene as described (Zuber et al., 2011a) . This enabled shRen.713). After confirming doxycycline induced DDX5 knockdown in these clones they were transplanted into the tail veins of sub-lethally irradiated primary recipient mice.
To remove artifacts of tissue culture the expression of the DDX5 or Renilla luciferase shRNAs were not induced in these mice, but instead a frank leukemia was allowed to develop to terminal stage after which the leukemic ladened spleens were collected from these primary transplant recipients. In addition to doxycycline inducible expression of dsRed-shRNA, RN2 cells also have constitutive expression of GFP driven by the PGK promoter. Therefore in the absence of doxycycline, the density of RN2 cells in cell suspensions prepared from the leukemic ladened spleens was measured using flow cytometry analysis of GFP positive cells. Spleen suspensions containing a total of 1,000,000 RN2 cells that encoded either of the DDX5 shRNAs or the shRen.713 control shRNA were then transplanted by tail vein injection into sub-lethally irradiated secondary recipient mice. RN2 cells constitutively express firefly luciferase enabling bioluminescence imaging of leukemia onset and progression in mice following transplantation. Doxycycline was provided to mice as described (Zuber et al., 2011b ) on day 5 following tail-vein transplantation of primary leukemia cells into the mice since leukemia was clearly detected in the mice at this timepoint. This timepoint 5 days posttransplantation when the mice were started on doxycycline-containing food and water is indicated as day 0 in Figure 2B and Figure S2A and S2B.
Transgenic DDX5 shRNA mice were developed as described in Dow et al. (Dow et al., 2012 ) that included targeting vector preparation, targeting vector transfection into KH2
ES cells, ES cell clone selection, and tetraploid embryo complementation. For targeting vector preparation the shDDX5.2086 shRNA was cloned using XhoI/EcoRI restriction sites into the cTGM plasmid. Breeding of founder mice was performed as described in Figure 
Co-expression network analysis:
Coexpression networks were constructed through meta-analysis of 23 human cancer studies that used a total of 1081 microarrays as previously described (Gillis and Pavlidis, 2011) . While statistical analysis can serve to determine the null expectation, we wanted a more targeted control dataset and so a brain-based co-expression network was also constructed from meta-analysis of 20 studies that used a total of 1851 microarrays (aggregated from the Gemma database) (Zoubarev et al., 2012) . Briefly, we included only large expression studies (minimally 20 samples each) conducted on the GPL570 array.
For each expression experiment, the absolute value of the correlation between gene pairs across samples was calculated. The correlations were then standardized to a uniform distribution between 0 and 1 and summed across experiments. This largely nonparametric approach decreases the potential role of any confound related to single experiments (such as batch effects), since each experiment has a minimal individual impact on the final coexpression data. The networks constructed are thus fully connected between all genes with varying weights reflecting the degree to which significant correlation was seen between the given pair of genes across many experiments. Each experiment was subject to a variety of quality control measures and these, as well as the underlying experimental data can be accessed at: A five-fold cross-validation was applied through voting of neighboring genes to estimate functional network connectivity (Gillis and Pavlidis, 2011) . Essentially we attempted to determine whether knowing four-fifths of genes annotated to a particular GO process or in the genes affected by DDX5 knockdown (q<0.05) would enable accurate prediction of the remaining one-fifth of genes in these gene sets. A receiver operator characteristic curve (ROC) score of 1.0 indicates that providing the cancer co-expression or brain-based co-expression networks enabled perfect prediction of the remaining one-fifth of genes and an ROC score of 0.5 indicates that our predictions were no better than random.
Q-PCR analysis of DDX5
RNA from RN2 AML cells transduced with transgenes encoding either HA-DDX5 WT ,
HA-DDX5 GNT , or HA-DDX5 DQAD was isolated from cells using the Qiagen RNeasy Mini Kit (catalog # 74104) that included the recommended on-column DNase digestion step.
cDNA was prepared from 1µg of each RNA sample using TaqMan 
Whole cell extract preparation from mouse organs:
Whole cell extract was prepared from intestinal epithelial cells as described (McJunkin et al., 2011) . Whole cell extracts were prepared by collecting bone marrow aspirates from mouse femur into PBS, washing cell pellets 5 minutes in ACK red blood cell lysis buffer (150mM NH 4 Cl, 10mM KHCO 3 , 0.1mM EDTA), then lysing cells in 2x SDS loading buffer (125mM Tris pH 6.8, 20% glycerol, 2% SDS, 2% Beta-mercaptoethanol, 0.1% Bromophenol blue). For other organs, the after dissection the organs were minced using a scalpel then homogenized in a modified RIPA buffer (Phosphate buffered saline solution containing 1% Triton X-100, 0.1% SDS, 150mM NaCl, 0.5% Sodium deoxycholate, 1mM EDTA, and Complete EDTA-free Protease Inhibitor cocktail -Roche catalog # 11873580001) using a dounce homogenizer and B-pestle. The homogenates were then centrifuged at maximum speed for 10 minutes at 4 degrees C in an Eppendorf
Microcentrifuge (Centrifuge 5417C). Supernatants were then diluted wit 2x SDS loading buffer for gel analysis.
Immunohistochemical Analysis
The indicated organs were dissected from mice and fixed overnight in 4%
paraformaldehyde. Organs were then washed in PBS. Samples were then processed in a Shandon Excelsior Tissue Processor and embedded in paraffin. Six micron sections were then cut and mounted onto VWR Superfrost Plus slides. The slides were then heated for 10 minutes at 60 degrees C to melt the paraffin. Deparaffinization was performed with two 10 minute washes with Xylene solution followed by two 5 minute incubations in 100% ethanol, two 2 minute incubations in 95% ethanol, and two 2 minute incubations in 75% ethanol to rehydrate the tissue sections. After washing 2x1min in distilled water slides were incubated for 10 minute in 3% H 2 O 2 /H 2 O to block endogenous peroxidase.
The slides were washed three times for 1 minute each in distilled water. Antigen retrieval was performed in Citrate buffer pH6.0 (Vector, H-3300) that included a 15 minute heated incubation in a Cuisinart Electric Pressure Cooker and 20 minute room temperature incubation. The slides were then rinsed in distilled water and washed two times for 5 minutes each in TBS. The slides were blocked in TBS + 1% BSA + 5% NHS for 1hr at room temperature followed by incubation overnight with primary antibody at 4 degrees 13 C. The next day the slides were rinsed three times in TBT for 10 minutes each. Slides were incubated with anti-rabbit (Vector, MP-7401) or anti-mouse (Vector, secondary antibodies for 30 minutes at room temperature followed by another three TBS rinses for 10 minutes each. The slides were incubated with peroxidase substrate (Vector,
ImmPACT DAB, SK-4105) for 3 minutes then rinsed in distilled water and counterstained with Hematoxylin. Finally the slides were rinsed in distilled water, dried, and protected with a coverslip using Surgipath mounting medium for analysis.
Histochemical analysis was performed in the Cold Spring Harbor Laboratory histochemical shared resource laboratory.
